UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:
August 12, 2020
Accession Number:
0001193125-20-215674
Submission Type:
POS AM
CIK:
0001680581
Company Name:
Fulcrum Therapeutics, Inc.
File Number:
333-239353